Outcomes Rocket

The future of market access belongs to organizations that plan years in advance. In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity, explains why pharmaceutical companies must prepare now for major market access changes coming in Europe and beyond. He highlights ...

AI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shap...

A non-invasive Alzheimer’s therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer’s therapy that uses senso...

Health economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commerc...

What started as a one-year break from surgery became a global medtech movement. In this episode, Dr. Dylan Attard, CEO and Co-founder of MedTech World, shares how his journey from surgical training to entrepreneurship led to the creation of MedTech World, now a global platform hosting events across ...